Screening and Brief Intervention (SBI) Implementation and Sustainability

侧重于非法药物使用的筛查和短暂干预研究人员没有定期论坛来交流想法和传播他们的工作。最近，物质滥用和精神卫生服务管理局(SAMHSA)物质滥用治疗(CSAT)筛查简短干预转诊和治疗计划(SBIRT)的项目主任和工作人员每年都会举行会议，但重点并不是研究。一些由NIDA支持的履行机构调查人员通过电话会议和现有会议(即药物依赖问题研究所)举行会议，NIDA计划召集这些研究人员(由SAMHSA/NIDA RFA-DA-08-021联合支持)于2010年9月举行一次会议。由于缺乏另一个论坛，一些毒品SBI调查人员将他们的工作带到了酒精问题简短干预国际网络(INEBRIA)，这是唯一一个专注于酒精SBI研究的专业组织，该组织定期但仅在美国以外举行会议。在酒精和其他毒品方面不断增加的活动和文献表明，现在是时候召开一次专业会议，重点关注美国的毒品SBI研究。 INEBRIA将于2011年9月22日至23日在波士顿举行会议，可能会得到美国国家酒精滥用和酒精中毒研究所(NIAAA)R-13的支持。这次会议提供了一个独特的机会：利用来自美国和世界各地的SBI研究人员将在这里举行的事实，前一天举行了一次全天的药物履行机构会议。印度国家石油公司的研究在美国发展得很好，重点正转向其他药物和实施研究。这次拟议的会议提供了一个机会，让这些研究人员和参加INEBRIA会议的研究人员聚在一起。这项申请提出了美国第一个将重点放在药物履行机构研究上的会议：一个履行机构实施研究会议。 这次履行机构执行情况研究会议的目标是审查关于药物履行机构执行情况的科学状况，着眼于解决办法和产生新的研究问题。会议的具体目标将是：1)确定和讨论酒精和其他药物履行机构执行(包括传播和可持续性)方面的已知和未知之处；2)分享适用于履行机构转译执行研究的研究方法；3)在初级研究人员之间以及在美国和世界各地的研究人员中产生新的履行机构执行研究想法和合作。为了实现这些目标，本次履行机构实施研究会议将在马萨诸塞州波士顿的履行机构研究中心召集不同的研究人员和临床医生，为期一天的会议。实现这些目标将提供一个论坛，让研究人员参与药物履行机构的研究，这是一个研究人员相对忽视的领域(与酒精履行机构相比)。此外，它还将导致分享许多尖端药物履行机构的研究想法，并在世界范围内传播这些想法，为推动该领域的发展提供一个独特的机会。

Screening and brief intervention (SBI) researchers focused on illicit drug use have no regular forum in which to share ideas and disseminate their work. Recently, project directors and staff from Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) Screening Brief Intervention Referral and Treatment (SBIRT) programs have met annually, but the focus has not been research. Some NIDA-supported SBI investigators meet by conference call and at existing meetings (i.e. College on Problems of Drug Dependence (CPDD)), and NIDA plans to bring together these researchers (supported by the joint SAMHSA/NIDA RFA-DA-08-021) for a meeting in September of 2010. Some drug SBI investigators, for lack of another forum, bring their work to the International Network on Brief Interventions for Alcohol Problems (INEBRIA), the only professional group focused on alcohol SBI research, a group that has held meetings regularly but only outside the US. Increasing activity and literature in the area of alcohol and other drug SBI suggest the time is right for a professional conference focused on drug SBI research in the US. INEBRIA will meet in Boston September 22-23, 2011, with possible National Institute on Alcohol Abuse and Alcoholism (NIAAA) R-13 support. That meeting presents a unique opportunity: to have a full-day drug SBI meeting the day before, taking advantage of the fact that SBI researchers from the US and around the world will be in town. SBI research is well-developed in the US and the focus is turning to other drugs and to implementation research. This proposed meeting presents an opportunity to bring these researchers together with researchers attending the INEBRIA meeting. This application proposes the first conference in the US to include a focus on drug SBI research: an SBI Implementation research conference. The goal of this SBI Implementation research conference is to review the state-of-the-science regarding drug SBI implementation with an eye towards both solutions and the generation of new research questions. The specific aims of the conference will be: 1) To identify and discuss what is known and not known about implementation (including dissemination and sustainability) of alcohol and other drug SBI; 2) To share research methods applicable to translational implementation research on SBI; 3) To generate new SBI implementation research ideas and collaborations among junior researchers and among those in the US and worldwide. To achieve these aims, this SBI Implementation research conference will convene a diverse group of researchers and clinicians in an epicenter of SBI research, Boston, Massachusetts, for a 1-day meeting. Achieving these aims will provide a forum for engaging researchers in drug SBI research, an area that has been relatively neglected by researchers (compared with alcohol SBI). In addition it will result in sharing numerous cutting edge drug SBI research ideas and dissemination of these ideas worldwide, providing a unique opportunity to advance the field.